 "After deferring to the DEA, your release reads that, 'FDA is the sole federal agency that approves drug products as safe and effective for intended indications.' Why then has the FDA failed to respond to the 1999 Institute of Medicine (IOM) report which concluded that marijuana's active components are potentially effective in treating pain, nausea, the anorexia of AIDS wasting, and other symptoms, and should be tested rigorously in clinical trials?